Abbott Laboratories (ABT) vs Novo Nordisk A/S (NVO)
NVO leads on 11 of 16 compared metrics.
A side-by-side comparison of Abbott Laboratories and Novo Nordisk A/S across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 16, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — ABT vs NVO
growth of $100 · last 30yABT +828.2%NVO +6188.8%NVO compounded faster
Log scale — wide-divergence pair
ABT NVO
ABT vs NVO: by the numbers
- •NVO is the larger company ($193.53B vs $156.41B market cap).
- •NVO trades at the lower earnings multiple (10.19 vs 24.70 P/E).
- •NVO converts more revenue to profit (37.14% vs 13.91% net margin).
- •NVO grew revenue faster over the past five years (20.73% vs 3.87% CAGR).
- •NVO pays the higher dividend yield (4.14% vs 2.75%).
Which is better, ABT or NVO?
Metric tally: ABT 5 · NVO 11It depends on what you're optimizing for:
ValueNVO(lower P/E)
GrowthNVO(faster 5Y revenue CAGR)
IncomeNVO(higher dividend yield)
QualityNVO(higher ROIC)
Metrics side by side
Valuation
| Metric | ABT | NVO |
|---|---|---|
| P/E ratio | 24.70 | 10.19● |
| Forward P/E | 14.65 | — |
| P/S ratio | 3.43● | 3.78 |
| P/B ratio | 2.98● | 6.19 |
| PEG ratio | 3.00● | 8.17 |
| EV / EBITDA | 16.25 | 7.35● |
| FCF yield | 4.76%● | 2.50% |
Profitability
| Metric | ABT | NVO |
|---|---|---|
| Gross margin | 56.38% | 81.83%● |
| Operating margin | 18.17% | 45.21%● |
| Net margin | 13.91% | 37.14%● |
| ROE | 12.06% | 60.74%● |
| ROIC | 8.43% | 29.53%● |
Dividends
| Metric | ABT | NVO |
|---|---|---|
| Dividend yield | 2.75% | 4.14%● |
| Payout ratio | 65.24% | 49.80% |
Growth (annualized)
| Metric | ABT | NVO |
|---|---|---|
| Revenue CAGR (5Y) | 3.87% | 20.73%● |
| EPS CAGR (5Y) | 8.22% | 19.59%● |
| FCF CAGR (5Y) | -0.61%● | -5.86% |
| Total return CAGR (5Y) | -2.17% | 2.95%● |
Frequently asked
- Which is better, ABT or NVO?
- It depends on your goal. value: NVO (lower P/E); growth: NVO (faster 5Y revenue CAGR); income: NVO (higher dividend yield); quality: NVO (higher ROIC). Across all compared metrics, NVO leads 11 to 5.
- Is ABT or NVO cheaper?
- On trailing earnings, NVO is cheaper: ABT trades at a 24.70 P/E and NVO at 10.19.
- Which has grown faster, ABT or NVO?
- Over the past five years, NVO grew revenue faster — ABT at a 3.87% CAGR versus NVO at 20.73%.
- Does ABT or NVO pay a bigger dividend?
- ABT yields 2.75% and NVO yields 4.14% based on trailing dividends and the latest price.
- Is ABT or NVO more profitable?
- NVO runs the higher net margin — ABT at 13.91% versus NVO at 37.14%.
- Which has been the better investment, ABT or NVO?
- Over the past 10-year, ABT delivered the higher annualized total return — ABT at 11.18% versus NVO at 7.84%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Abbott Laboratories P/E ratioNovo Nordisk A/S P/E ratioAbbott Laboratories dividend yieldNovo Nordisk A/S dividend yieldAbbott Laboratories ROENovo Nordisk A/S ROEAbbott Laboratories operating marginNovo Nordisk A/S operating marginAbbott Laboratories revenue growthNovo Nordisk A/S revenue growthAbbott Laboratories free cash flowNovo Nordisk A/S free cash flow
Abbott Laboratories & Novo Nordisk A/S appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 16, 2026.